Yoo Seok Park

Prof. Dr. Yoo Seok Park

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Shock
Verified
Journal Article
Closed access
GOGeun Ho Oh
Geun Ho Oh
SCSung Phil Chung
Sung Phil Chung
YPYoo Seok Park
Yoo Seok Park
JHJung Hwa Hong
Jung Hwa Hong
HLHye Sun Lee
Hye Sun Lee
IPIncheol Park
Incheol Park
We evaluated the mean platelet volume (MPV) to platelet ratio to determine its significance as a prognostic marker for early mortality in critically ill patients with suspected sepsis receiving early goal-directed therapy (EGDT). We retrospectively reviewed the records from a prospective EGDT registry and screened eligible adult patients who were admitted to the emergency department (ED) with severe sepsis and/or septic shock. The MPV/platelet ratio was estimated as the MPV value divided by the platelet count on each day of hospitalization. The clinical outcome was 28-day mortality. We included 120 patients receiving EGDT. In the multivariate Cox proportional hazard models, higher MPV/platelet ratios on admission (HR: 1.04; 95% CI: 1.015–1.066; P = 0.002) and at 24 h (HR: 1.032; 95% CI: 1.012–1.054; P = 0.002) were significant risk factors for mortality at 28 days. An increased trend for 28-day mortality was associated with a MPV/platelet ratio >3.71 on admission (HR: 4.274; 95% CI: 1.228–14.874; P = 0.023) and a higher MPV/platelet ratio (>6.49) at 24 h (HR: 2.719; 95% CI: 1.048–7.051; P = 0.04) in patients with severe sepsis receiving EGDT. In our study, MPV or platelet count alone did not predict shock and 28-day mortality in patients with severe sepsis receiving EGDT. However, the MPV/platelet ratio at ED admission and on day 1 is a promising prognostic marker for 28-day mortality in patients with severe sepsis.

29 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SRSeung Mok Ryoo
Seung Mok Ryoo
KHKap Su Han
Kap Su Han
SAShin Ahn
Shin Ahn
TSTae Gun Shin
Tae Gun Shin
SHSung Yeon Hwang
Sung Yeon Hwang
BKByuk Sung Ko
Byuk Sung Ko
The objective of this study was to evaluate the prognostic value of C-reactive protein (CRP), procalcitonin (PCT), and their combination for mortality in patients with septic shock. This multicenter, prospective, observational study was conducted between November 2015 and December 2017. A total of 1,772 septic shock patients were included, and the overall 28-day mortality was 20.7%. Although both CRP and PCT were elevated in the non-survivor group, only CRP had statistical significance (11.9 mg/dL vs. 14.7 mg/dL, p = 0.003, 6.4 ng/mL vs. 8.2 ng/mL, p = 0.508). Multivariate analysis showed that CRP and PCT were not independent prognostic markers. In the subgroup analysis of the CRP and PCT combination matrix using their optimal cut-off values (CRP 14.0 mg/dL, PCT 17.0 ng/dL), both CRP and PCT elevated showed significantly higher mortality (Odds ratio 1.552 [95% Confidence intervals 1.184–2.035]) than both CRP and PCT not elevated (p = 0.001) and only PCT elevated (p = 0.007). However, both CRP and PCT elevated was also not an independent predictor in multivariate analysis. Initial levels of CRP and PCT alone and their combinations in septic shock patients had a limitation to predict 28-day mortality. Future research is needed to determine new biomarkers for early prognostication in patients with septic shock.

1 March 2013 in Resuscitation
Verified
Journal Article
Closed access
MKMin Joung Kim
Min Joung Kim
YPYoo Seok Park
Yoo Seok Park
SKSeung Whan Kim
Seung Whan Kim
YYYoo Sang Yoon
Yoo Sang Yoon
KLKyeong Ryong Lee
Kyeong Ryong Lee
SCSung Phil Chung
Sung Phil Chung

1 January 2016 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
MSMin Ho Seo
Min Ho Seo
MCMinhong Choa
Minhong Choa
JYJe Sung You
Je Sung You
HLHye Sun Lee
Hye Sun Lee
JHJung Hwa Hong
Jung Hwa Hong
IPIncheol Park
Incheol Park
Seo MH, et al. Yonsei Med J. 2016 Nov;57(6):1361-1369. https://doi.org/10.3349/ymj.2016.57.6.1361

1 May 2008 in Emergency Medicine Journal
Verified
Journal Article
Closed access
PDF file
HKH J Kim
H J Kim
SCSung Phil Chung
Sung Phil Chung
IPIncheol Park
Incheol Park
JCJunho Cho
Junho Cho
HLH S Lee
H S Lee
YPYoo Seok Park
Yoo Seok Park
Objective: To compare the GlideScope video laryngoscope (GVL) with the classic Macintosh laryngoscope in simulated airway scenarios of varying difficulty. Materials and methods: A prospective, crossover and randomised study was performed. Four airway scenarios were simulated using the Airsim model as follows: normal; cervical spine immobilisation; tongue oedema and combined cervical spine immobilisation with tongue oedema. Emergency physicians performed tracheal intubations using both devices in each of the scenarios. The time required to intubate, the success rate and the number of intubation attempts were recorded. At the end of each scenario, participants scored vocal cord visualisation using the percentage of glottic opening (POGO) visible and the subjective ease of intubation on a visual analogue scale (VAS). Results: All 25 participants successfully completed the study. There was no difference in the time required for successful tracheal intubation using the GVL compared with using the Macintosh laryngoscope in the four airway scenarios. Only one participant failed to intubate the trachea with the Macintosh laryngoscope for the combined scenario. There was a significant increase in POGO when using the GVL in the cervical spine immobilisation group (p = 0.027). The VAS score of the subjective ease of intubation was lower for the GVL than for the Macintosh laryngoscope device in difficult scenarios but this difference was not significant. Conclusion: This study suggests that the GVL could be an option for airway management even by emergency physicians with little experience and no training in its use.